Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Development of novel cancer therapeutic antibodies targeting the tumor stroma

Reference number
Coordinator BioInvent International Aktiebolag
Funding from Vinnova SEK 7 500 000
Project duration July 2009 - June 2012
Status Completed

Last updated 25 November 2019

Reference number 2009-00101